Chiang Mai Ram Medical Business Public Company Limited(CMR.BK)
No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | 3,668 | 4,193 | 5,205 | 5,066 | 5,288 | 2,496 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | 198 | 292 | 504 | 218 | 131 | 2,446 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Chiang Mai Ram Medical Business Public Company Limited is a Thai healthcare provider primarily operating medical facilities. The company delivers a comprehensive array of medical services, encompassing core specializations such as internal medicine, cardiology, general practice, pediatrics, orthopedics, various surgical fields (general and pediatric), obstetrics-gynecology, radiology, dentistry, anesthesiology, otolaryngology (ENT), and ophthalmology. Beyond these fundamental areas, CMR.BK manages specialized clinics for conditions like urological, neurological, endocrine, oncological, hematological, plastic surgery, gastrointestinal, and dermatological issues, alongside dedicated clinics for infertility and gynecologic oncology. The company further extends its offerings to include a variety of diagnostic and therapeutic services such as dental care, advanced imaging (X-ray, CT colonoscopy), cardiac catheterization, gynecologic cancer treatments, back pain management, physical therapy and rehabilitation, surgical operating theatres, laboratory examinations (including real-time PCR), ambulance services, CRD, and comprehensive health check-ups. Additionally, it provides insurance products. CMR.BK operates its primary medical care center under the name Lanna Hospital. Established in 1974, the company's headquarters are located in Chiang Mai, Thailand. It functions as a subsidiary of Vibhavadi Medical Center Public Company Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Chiang Mai Ram Medical Business Public Company Limited (CMR.BK)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Chiang Mai Ram Medical Business Public Company Limited is a Thai healthcare provider primarily operating medical facilities. The company delivers a comprehensive array of medical services, encompassing core specializations such as internal medicine, cardiology, general practice, pediatrics, orthopedics, various surgical fields (general and pediatric), obstetrics-gynecology, radiology, dentistry, anesthesiology, otolaryngology (ENT), and ophthalmology. Beyond these fundamental areas, CMR.BK manages specialized clinics for conditions like urological, neurological, endocrine, oncological, hematological, plastic surgery, gastrointestinal, and dermatological issues, alongside dedicated clinics for infertility and gynecologic oncology. The company further extends its offerings to include a variety of diagnostic and therapeutic services such as dental care, advanced imaging (X-ray, CT colonoscopy), cardiac catheterization, gynecologic cancer treatments, back pain management, physical therapy and rehabilitation, surgical operating theatres, laboratory examinations (including real-time PCR), ambulance services, CRD, and comprehensive health check-ups. Additionally, it provides insurance products. CMR.BK operates its primary medical care center under the name Lanna Hospital. Established in 1974, the company's headquarters are located in Chiang Mai, Thailand. It functions as a subsidiary of Vibhavadi Medical Center Public Company Limited.